Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 16 JUNE 2023

The Alphabet Soup Of ESG: Introducing Key Frameworks

Cooley LLP
Explore more from Cooley LLP

ESG? SDGs? SASB? GRI? TCFD? The world of ESG (Environmental, Social and Governance) is littered with acronyms and can seem like an alphabet soup to companies just getting started.

GlobalCorporate/Commercial Law
Beth Sasfai
Beth Sasfai
Author LinkedIn connections

ESG? SDGs? SASB? GRI? TCFD? The world of ESG (Environmental, Social and Governance) is littered with acronyms and can seem like an alphabet soup to companies just getting started. This article introduces you to some of the most common ESG standards and frameworks that are relevant to private companies.

United Nations Sustainable Development Goals (UN SDGs)

Who it's relevant to: any ESG-focused company.

The United Nations Sustainable Development Goals (UN SDGs) were adopted by all United Nations Member States in 2015 as a "a blueprint to achieve a better and more sustainable future for all". The framework features 17 goals that are focused on reducing global inequality by ending poverty, addressing racial and gender disparities, improving access to healthcare and education, and tackling climate change. Though the goals are broad and interdependent, the UN has adopted specific targets for each goal, along with indicators that are being used to measure

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP